{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:56:34Z","timestamp":1784735794757,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.urology.2015.12.009","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T17:45:37Z","timestamp":1450892737000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML)"],"prefix":"10.1016","volume":"89","author":[{"given":"Anil","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9044-008X","authenticated-orcid":false,"given":"Louis","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8192-0508","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Lattouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"York","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-8384","authenticated-orcid":false,"given":"Ricardo","family":"Rendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Card","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2015.12.009_bib0010","first-page":"211","article-title":"Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex","volume":"7","author":"Franz","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.urology.2015.12.009_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","article-title":"Tuberous sclerosis complex: advances in diagnosis, genetics, and management","volume":"57","author":"Schwartz","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.urology.2015.12.009_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbapap.2009.12.001","article-title":"Dissecting the role of mTOR: lessons from mTOR inhibitors","volume":"1804","author":"Dowling","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.urology.2015.12.009_bib0025","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.urology.2015.12.009_bib0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00247-014-3147-1","article-title":"Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome","volume":"45","author":"Back","year":"2014","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.urology.2015.12.009_bib0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.urology.2015.12.009_bib0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.urology.2015.12.009_bib0045","author":"Owens"},{"key":"10.1016\/j.urology.2015.12.009_bib0050","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1159\/000320891","article-title":"Tuberous sclerosis complex renal disease","volume":"118","author":"Dixon","year":"2011","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.urology.2015.12.009_bib0055","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2015.12.009_bib0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1148\/radiol.2251011477","article-title":"Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture","volume":"225","author":"Yamakado","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.urology.2015.12.009_bib0065","first-page":"229","article-title":"Tuberous sclerosis complex: perioperative considerations","volume":"14","author":"Rabito","year":"2014","journal-title":"Ochsner J"},{"key":"10.1016\/j.urology.2015.12.009_bib0070","first-page":"349","article-title":"Tuberous sclerosis complex with end-stage renal failure","volume":"10","author":"Neumann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.urology.2015.12.009_bib0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/oxfordjournals.ndt.a027315","article-title":"Chronic renal failure and its treatment in tuberous sclerosis","volume":"11","author":"Schillinger","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.urology.2015.12.009_bib0080","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urology.2015.12.009_bib0085","first-page":"367","article-title":"Guidelines for the management of tuberous sclerosis complex renal disease","volume":"22","author":"Rouviere","year":"2012","journal-title":"Prog Urol"},{"key":"10.1016\/j.urology.2015.12.009_bib0090","author":"Torres"},{"key":"10.1016\/j.urology.2015.12.009_bib0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3348\/kjr.2013.14.2.337","article-title":"FDG PET or PET\/CT in evaluation of renal angiomyolipoma","volume":"14","author":"Lin","year":"2013","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.urology.2015.12.009_bib0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/2156-7514.83230","article-title":"Clinically relevant imaging in tuberous sclerosis","volume":"1","author":"Radhakrishnan","year":"2011","journal-title":"J Clin Imaging Sci"},{"key":"10.1016\/j.urology.2015.12.009_bib0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00261-014-0083-3","article-title":"Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management","volume":"39","author":"Jinzaki","year":"2014","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.urology.2015.12.009_bib0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.crad.2009.09.014","article-title":"The radiological diagnosis and treatment of renal angiomyolipoma-current status","volume":"65","author":"Halpenny","year":"2010","journal-title":"Clin Radiol"},{"key":"10.1016\/j.urology.2015.12.009_bib0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","article-title":"Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands","volume":"66","author":"Eijkemans","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.urology.2015.12.009_bib0120","first-page":"2056","article-title":"Clinical analysis of tuberous sclerosis complex complicated with renal angiomyolipoma: a report of 22 cases]","volume":"93","author":"Ting","year":"2013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.urology.2015.12.009_bib0125","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1097\/01.ju.0000177497.31986.64","article-title":"Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex","volume":"174","author":"Ewalt","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.12.009_bib0130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.juro.2015.04.081","article-title":"Transarterial embolization of angiomyolipoma: a systematic review","volume":"194","author":"Murray","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.12.009_bib0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.ajkd.2005.09.028","article-title":"Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex","volume":"47","author":"Williams","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.urology.2015.12.009_bib0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2490-14-77","article-title":"Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR inhibition","volume":"14","author":"Krummel","year":"2014","journal-title":"BMC Urol"},{"key":"10.1016\/j.urology.2015.12.009_bib0145","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.juro.2006.06.013","article-title":"Laparoscopic cryoablation of renal angiomyolipoma","volume":"176","author":"Byrd","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.12.009_bib0150","article-title":"Percutaneous microwave ablation of renal angiomyolipomas","author":"Cristescu","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.urology.2015.12.009_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1464-410X.2009.08649.x","article-title":"Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated","volume":"105","author":"Sooriakumaran","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2015.12.009_bib0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2015.12.009_bib0165","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ndt\/gfu013","article-title":"The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1","volume":"29","author":"Kingswood","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.urology.2015.12.009_bib0170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2015.12.009_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1750-1172-7-87","article-title":"Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two year trial","volume":"7","author":"Cabrera-Lopez","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.urology.2015.12.009_bib0180","doi-asserted-by":"crossref","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urology.2015.12.009_bib0185","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2015.12.009_bib0190","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.urology.2008.07.049","article-title":"Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms","volume":"72","author":"Seyam","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urology.2015.12.009_bib0195","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/ajkd.2002.32770","article-title":"Reduction of postembolization syndrome after ablation of renal angiomyolipoma","volume":"39","author":"Bissler","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.urology.2015.12.009_bib0200","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S1569-9056(15)60004-5","article-title":"Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex (TSC) from EXIST-2: continued efficacy and diminishing adverse events after ~3.5 years of treatment","volume":"14","author":"Bissler","year":"2015","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.urology.2015.12.009_bib9010","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1016\/S1569-9056(14)61119-2","article-title":"Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex (TSC): EXIST-2 3-year follow-up","volume":"13","author":"Bissler","year":"2014","journal-title":"European Urology Supplements"},{"key":"10.1016\/j.urology.2015.12.009_bib0205","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","article-title":"Renal angiomyolipomata","volume":"66","author":"Bissler","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.urology.2015.12.009_bib0210","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2015.12.009_bib0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","article-title":"Strategies for the management of adverse events associated with mTOR inhibitors","volume":"28","author":"Kaplan","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.urology.2015.12.009_bib0225","first-page":"MJ01","article-title":"Angiomyolipomas, renal cell carcinomas and pulmonary lymphangioleiomyomatosis","volume":"8","author":"Vlachostergios","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.urology.2015.12.009_bib0230","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2015.12.009_bib0235","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2015.12.009_bib0240","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5858\/2009-0637-RSR.1","article-title":"Epithelioid angiomyolipoma: a morphologically distinct variant that mimics a variety of intra-abdominal neoplasms","volume":"135","author":"Mete","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urology.2015.12.009_bib0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/radiology.188.1.8511293","article-title":"Hyperechoic renal tumors: anechoic rim and intratumoral cysts in US differentiation of renal cell carcinoma from angiomyolipoma","volume":"188","author":"Yamashita","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.urology.2015.12.009_bib0250","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.urology.2015.12.009_bib0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjmed.2014.07.042","article-title":"Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs","volume":"128","author":"Chen","year":"2015","journal-title":"Am J Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515011437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515011437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T16:17:09Z","timestamp":1653927429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429515011437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":50,"alternative-id":["S0090429515011437"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2015.12.009","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML)","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2015.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}